213 related articles for article (PubMed ID: 34586700)
1. "A Study in Yellow": Investigations in the Stereoselectivity of Ene-Reductases.
Parmeggiani F; Brenna E; Colombo D; Gatti FG; Tentori F; Tessaro D
Chembiochem; 2022 Jan; 23(1):e202100445. PubMed ID: 34586700
[TBL] [Abstract][Full Text] [Related]
2. Recombinant S. cerevisiae expressing Old Yellow Enzymes from non-conventional yeasts: an easy system for selective reduction of activated alkenes.
Romano D; Contente ML; Molinari F; Eberini I; Ruvutuso E; Sensi C; Amaretti A; Rossi M; Raimondi S
Microb Cell Fact; 2014 Apr; 13():60. PubMed ID: 24767246
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the stereochemical course of ene reductase-catalysed reactions by deuterium labelling.
Brenna E; Fronza G; Fuganti C; Parmeggiani F
Isotopes Environ Health Stud; 2015; 51(1):24-32. PubMed ID: 25675259
[TBL] [Abstract][Full Text] [Related]
4. Asymmetric Ene-Reduction by F
Kang SW; Antoney J; Lupton DW; Speight R; Scott C; Jackson CJ
Chembiochem; 2023 Apr; 24(8):e202200797. PubMed ID: 36716144
[TBL] [Abstract][Full Text] [Related]
5. Stereoselectivity Switch in the Reduction of α-Alkyl-β-Arylenones by Structure-Guided Designed Variants of the Ene Reductase OYE1.
Crotti M; Parmeggiani F; Ferrandi EE; Gatti FG; Sacchetti A; Riva S; Brenna E; Monti D
Front Bioeng Biotechnol; 2019; 7():89. PubMed ID: 31080798
[TBL] [Abstract][Full Text] [Related]
6. Old yellow enzymes: structures and structure-guided engineering for stereocomplementary bioreduction.
Shi Q; Wang H; Liu J; Li S; Guo J; Li H; Jia X; Huo H; Zheng Z; You S; Qin B
Appl Microbiol Biotechnol; 2020 Oct; 104(19):8155-8170. PubMed ID: 32830294
[TBL] [Abstract][Full Text] [Related]
7. Selectivity through discriminatory induced fit enables switching of NAD(P)H coenzyme specificity in Old Yellow Enzyme ene-reductases.
Iorgu AI; Hedison TM; Hay S; Scrutton NS
FEBS J; 2019 Aug; 286(16):3117-3128. PubMed ID: 31033202
[TBL] [Abstract][Full Text] [Related]
8. Chemoenzymatic asymmetric synthesis of pregabalin precursors via asymmetric bioreduction of β-cyanoacrylate esters using ene-reductases.
Winkler CK; Clay D; Davies S; O'Neill P; McDaid P; Debarge S; Steflik J; Karmilowicz M; Wong JW; Faber K
J Org Chem; 2013 Feb; 78(4):1525-33. PubMed ID: 23316696
[TBL] [Abstract][Full Text] [Related]
9. Asymmetric Ene-Reduction of α,β-Unsaturated Compounds by F
Kang SW; Antoney J; Frkic RL; Lupton DW; Speight R; Scott C; Jackson CJ
Biochemistry; 2023 Feb; 62(3):873-891. PubMed ID: 36637210
[TBL] [Abstract][Full Text] [Related]
10. Thermal, electrochemical and photochemical reactions involving catalytically versatile ene reductase enzymes.
Toogood HS; Scrutton NS
Enzymes; 2020; 47():491-515. PubMed ID: 32951833
[TBL] [Abstract][Full Text] [Related]
11. Comparative characterization of novel ene-reductases from cyanobacteria.
Fu Y; Castiglione K; Weuster-Botz D
Biotechnol Bioeng; 2013 May; 110(5):1293-301. PubMed ID: 23280373
[TBL] [Abstract][Full Text] [Related]
12. C3 and C6 Modification-Specific OYE Biotransformations of Synthetic Carvones and Sequential BVMO Chemoenzymatic Synthesis of Chiral Caprolactones.
Issa IS; Toogood HS; Johannissen LO; Raftery J; Scrutton NS; Gardiner JM
Chemistry; 2019 Feb; 25(12):2983-2988. PubMed ID: 30468546
[TBL] [Abstract][Full Text] [Related]
13. Ene-Reductase: A Multifaceted Biocatalyst in Organic Synthesis.
Kumar Roy T; Sreedharan R; Ghosh P; Gandhi T; Maiti D
Chemistry; 2022 Apr; 28(21):e202103949. PubMed ID: 35133702
[TBL] [Abstract][Full Text] [Related]
14. Identification of four ene reductases and their preliminary exploration in the asymmetric synthesis of (R)-dihydrocarvone and (R)-profen derivatives.
Shi Q; Jia Y; Wang H; Li S; Li H; Guo J; Dou T; Qin B; You S
Enzyme Microb Technol; 2021 Oct; 150():109880. PubMed ID: 34489033
[TBL] [Abstract][Full Text] [Related]
15. Asymmetric Reductive Carbocyclization Using Engineered Ene Reductases.
Heckenbichler K; Schweiger A; Brandner LA; Binter A; Toplak M; Macheroux P; Gruber K; Breinbauer R
Angew Chem Int Ed Engl; 2018 Jun; 57(24):7240-7244. PubMed ID: 29689601
[TBL] [Abstract][Full Text] [Related]
16. Biocatalytic synthesis of enantiopure building blocks for pharmaceuticals.
Simon RC; Mutti FG; Kroutil W
Drug Discov Today Technol; 2013; 10(1):e37-44. PubMed ID: 24050228
[TBL] [Abstract][Full Text] [Related]
17. Asymmetric bioreduction of activated C=C bonds using enoate reductases from the old yellow enzyme family.
Stuermer R; Hauer B; Hall M; Faber K
Curr Opin Chem Biol; 2007 Apr; 11(2):203-13. PubMed ID: 17353140
[TBL] [Abstract][Full Text] [Related]
18. Structural insights into the ene-reductase synthesis of profens.
Waller J; Toogood HS; Karuppiah V; Rattray NJW; Mansell DJ; Leys D; Gardiner JM; Fryszkowska A; Ahmed ST; Bandichhor R; Reddy GP; Scrutton NS
Org Biomol Chem; 2017 May; 15(20):4440-4448. PubMed ID: 28485453
[TBL] [Abstract][Full Text] [Related]
19. Biocatalytic reduction of activated CC-bonds and beyond: emerging trends.
Winkler CK; Faber K; Hall M
Curr Opin Chem Biol; 2018 Apr; 43():97-105. PubMed ID: 29275291
[TBL] [Abstract][Full Text] [Related]
20. Biocatalytic Reduction Reactions from a Chemist's Perspective.
Hollmann F; Opperman DJ; Paul CE
Angew Chem Int Ed Engl; 2021 Mar; 60(11):5644-5665. PubMed ID: 32330347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
